BACKGROUND: Minimally invasive pancreaticoduodenectomy (PD) remains one of the most challenging abdominal procedures and its application in the elderly population is poorly reported in the literature so far. The goal of this study was to demonstrate that robot-assisted PD can be safely performed in patients aged 70 years and older. METHODS: Forty-one consecutive robot-assisted PD performed between April 2007 and January 2010 were prospectively entered in a dedicated database. Patients were stratified into two groups: group 1, aged > or =70 years (n = 15, 36.6%); and group 2, aged <70 years (n = 26, 63.4%). The data were reviewed retrospectively. RESULTS: Indications for surgery and patient characteristics were the same in both groups, with the exception of age. There was no statistical difference in terms of operative time (P = 0.376), blood loss (P = 0.989), conversion rate (P = 0.52), mortality (P = 0.36), or overall morbidity rate (P = 0.74). The mean hospital stay was 14.3 days in group 1 and 11.2 days in group 2. This was not statistically significant (P = 0.136). CONCLUSIONS: Robot-assisted pancreaticoduodenectomy can be performed safely in elderly patients with comparable mortality, morbidity, and outcomes compared with a younger population. Age alone should not be a contraindication for robotic pancreatic resection.
BACKGROUND: Minimally invasive pancreaticoduodenectomy (PD) remains one of the most challenging abdominal procedures and its application in the elderly population is poorly reported in the literature so far. The goal of this study was to demonstrate that robot-assisted PD can be safely performed in patients aged 70 years and older. METHODS: Forty-one consecutive robot-assisted PD performed between April 2007 and January 2010 were prospectively entered in a dedicated database. Patients were stratified into two groups: group 1, aged > or =70 years (n = 15, 36.6%); and group 2, aged <70 years (n = 26, 63.4%). The data were reviewed retrospectively. RESULTS: Indications for surgery and patient characteristics were the same in both groups, with the exception of age. There was no statistical difference in terms of operative time (P = 0.376), blood loss (P = 0.989), conversion rate (P = 0.52), mortality (P = 0.36), or overall morbidity rate (P = 0.74). The mean hospital stay was 14.3 days in group 1 and 11.2 days in group 2. This was not statistically significant (P = 0.136). CONCLUSIONS: Robot-assisted pancreaticoduodenectomy can be performed safely in elderly patients with comparable mortality, morbidity, and outcomes compared with a younger population. Age alone should not be a contraindication for robotic pancreatic resection.
Authors: C Palanivelu; P S Rajan; M Rangarajan; V Vaithiswaran; P Senthilnathan; R Parthasarathi; P Praveen Raj Journal: J Hepatobiliary Pancreat Surg Date: 2009-08-04
Authors: Pier Cristoforo Giulianotti; Fabio Sbrana; Francesco Maria Bianco; Enrique Fernando Elli; Galaxy Shah; Pietro Addeo; Giuseppe Caravaglios; Andrea Coratti Journal: Surg Endosc Date: 2010-01-09 Impact factor: 4.584
Authors: Erin H Baker; Samuel W Ross; Ramanathan Seshadri; Ryan Z Swan; David A Iannitti; Dionisios Vrochides; John B Martinie Journal: J Gastrointest Oncol Date: 2015-08
Authors: May C Tee; Kristopher P Croome; Christopher R Shubert; Michael B Farnell; Mark J Truty; Florencia G Que; K Marie Reid-Lombardo; Rory L Smoot; David M Nagorney; Michael L Kendrick Journal: HPB (Oxford) Date: 2015-08-20 Impact factor: 3.647
Authors: Thijs de Rooij; Sjors Klompmaker; Mohammad Abu Hilal; Michael L Kendrick; Olivier R Busch; Marc G Besselink Journal: Nat Rev Gastroenterol Hepatol Date: 2016-02-17 Impact factor: 46.802
Authors: Antonio Luiz de Vasconcellos Macedo; Vladimir Schraibman; Samuel Okazaki; Fernando Concilio Mauro; Marina Gabrielle Epstein; Suzan Menasce Goldman; Suzana A S Lustosa; Delcio Matos Journal: J Robot Surg Date: 2011-01-07